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Abstract 
Background: Optimal sedation and analgesia is a challenge in paediatric intensive care units (PICU) because of dif-
ficulties in scoring systems and specific metabolism inducing tolerance and withdrawal. Excessive sedation is associ-
ated with prolonged mechanical ventilation and hospitalisation. Adult and paediatric data suggest that goal-directed 
sedation algorithms reduce the duration of mechanical ventilation. We implemented a nurse-driven sedation proto-
col in a PICU and evaluated its impact.
Methods: We conducted a before and after protocol implementation study in a population of children aged 
0–18 years who required mechanical ventilation for at least 24 h between January 2013 and March 2015. After the 
protocol implementation in January 2014, nurses managed analgesia and sedation following an algorithm that 
included the COMFORT behaviour scale (COMFORT-B). Duration of mechanical ventilation was the primary outcome; 
secondary outcomes were total doses and duration of medications, PICU length of stay, incidence of ventilator-asso-
ciated pneumonia, and occurrence of withdrawal symptoms. Pre–post analysis followed with segmented regression 
analysis of interrupted time series was used to assess the effect of protocol.
Results: A total of 200 children were analysed, including 107 before implementation and 93 children after imple-
mentation of the protocol. After implementation of the protocol, the total number of COMFORT-B scores per day of 
mechanical ventilation significantly increased from 3.9 ± 2.5 times during the pre-implementation period to 6.6 ± 3.5 
times during the post-implementation period (p < 10−3). Mean duration of mechanical ventilation tended to be 
lower in the post-implementation period (8.3 ± 7.3 vs 6.6 ± 5.6 days, p = 0.094), but changes in either the trend per 
trimester from pre-implementation to post-implementation (p = 0.933) or the immediate change after implementa-
tion (p = 0.923) were not significant with segmented regression analysis. No significant change between pre- and 
post-implementation was shown for total dose of sedatives, withdrawal symptoms, agitation episodes, or unplanned 
endotracheal extubations.
Conclusions: These results were promising and suggested that implementation of a nurse-driven sedation protocol 
in a PICU was feasible. Evaluation of sedation and analgesia was better after the protocol implementation; duration of 
mechanical ventilation and occurrence of withdrawal symptoms tended to be reduced.
Keywords: PICU, Nurse-driven sedation protocol, Mechanical ventilation, Withdrawal symptoms, COMFORT-B score, 
Opioid, Benzodiazepine, Evaluation, Feasibility
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Background
Management of analgesia and sedation is an integral 
component of medical care for critically ill children. Its 
role is to assure the comfort and safety of a patient under-
going painful treatments and technical procedures. It can 
also be, particularly in  situations like acute respiratory 
distress syndrome (ARDS) or acute brain injury, a full 
processing treatment [1].
Optimal sedation is described as a patient under seda-
tion who can easily be woken up and who can undergo 
medical care and procedures. On both sides of this opti-
mal state are the states of “oversedation” and “underse-
dation”, both with major drawbacks. Excessive sedation is 
associated with poor outcomes like prolonged mechani-
cal ventilation, longer hospitalisation, more nosocomial 
infections, and more frequent withdrawal symptoms 
[2–4]. Insufficient sedation involves risks of agitation 
and complications like unplanned extubation or catheter 
removal.
In a literature review in the paediatric population, 
Vet et  al. [5] showed that optimal sedation is obtained 
in only 60% of children and that “oversedation” is more 
frequent than “undersedation” (30% versus 10%). Recom-
mendations in paediatric populations are rare, but most 
of the time the combination of an opioid and a sedative 
is used. Playfor et al. [6] recommended using morphine 
or fentanyl with midazolam in a continuous intravenous 
perfusion. A survey published in Critical Care Medicine 
by Kudchadkar et al. [7] done in paediatric intensive care 
units (PICU) all over the world reported that 72% of the 
centres used opioids and benzodiazepines together and 
only 2% use ketamine or propofol.
Good management of sedation and analgesia is partly 
based on good evaluation and requires validated, simple, 
and reproducible scores. Many different scores exist to 
evaluate pain in children, but only the COMFORT scale 
is validated in children under sedation. Derived from 
the COMFORT scale, the COMFORT behaviour scale 
(COMFORT-B) was published by Ista et  al. [8]. This 
scale excludes the physiologic items from the COM-
FORT scale and retains only the behavioural items. It 
showed very good correlation with the Nurse Interpreta-
tion Score of Sedation. In Kudchadkar’s survey [7], even 
so only 42% of PICUs routinely used an objective seda-
tion score.
Sedation and analgesia is particularly challenging in 
children with regards to a specific metabolism because 
tolerance and withdrawal phenomena are frequently 
observed in cases of prolonged administration [9]. Many 
studies have proved that continuous intravenous per-
fusion of drugs is associated with longer mechanical 
ventilation [2, 3]. Recent years have seen emerging tech-
niques of goal-directed sedation. These include daily 
interruption of sedatives and nurse-driven protocols. In 
adults, Kress et  al. [10] evaluated daily interruption of 
sedatives and showed a significant reduction in the dura-
tion of mechanical ventilation, length of hospital stay, 
and cumulative doses of midazolam and opioids. Nurse-
driven sedation and analgesia protocols were evalu-
ated in adults and, despite interesting results [11–13], a 
Cochrane review in 2015 concluded that there was insuf-
ficient evidence to evaluate the effectiveness of protocol-
directed sedation [14]. In paediatric units, goal-directed 
sedation protocols were also developed but few studies 
were found in the literature, with unclear results [15–17]. 
Recently, a randomised controlled trial among children 
admitted in PICU for acute lung injury showed no dif-
ference in duration of ventilation regardless of sedation 
protocol or usual care implementation [18]. Daily inter-
ruption of sedation was also studied in PICU: Gupta et al. 
[19] and Verlaat et  al. [20] showed a significant reduc-
tion in duration of mechanical ventilation, PICU length 
of stay, and duration of benzodiazepine perfusion with 
a daily sedation interruption protocol. However, more 
recently a RCT including 129 patients [21] under seda-
tion protocol assessed the impact of daily sedation inter-
ruption in critically ill children and no improvement of 
clinical outcomes was found; an increased mortality was 
even found in the group with daily sedation interruption 
without any evidence of a relationship.
The aim of this study was to evaluate the impact of a 
nurse-driven sedation protocol implemented at a PICU 
on the duration of mechanical ventilation, total dose of 
sedatives, length of stay in the PICU, incidence of ventila-




The study was set up between January 2013 and March 
2015 at a 23-bed medical–surgical PICU of a university-
affiliated teaching hospital, counting 10 intensivists and 
65 nurses. Newborns and post-cardiac surgery patients 
were not admitted in our PICU. The nurse/patient ratio 
was 1:2 in the two periods of the study. Mechanically ven-
tilated patients aged from 0 to 18 years receiving sedation 
for more than 24 h were included in the study. Patients 
who were transferred from another PICU where seda-
tive drugs had already been initiated and patients with 
tracheostomy were excluded from the study. No written 
ventilation weaning protocol existed in the PICU. Spon-
taneous breathing tests with T-piece, pressure support or 
pressure support and CPAP before mechanical ventila-
tion weaning were performed as stated by the French rec-
ommendations [22]. Weaning criteria are checked at least 
twice a day. Neither nurses nor respiratory therapists or 
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physiotherapists are usually involved in ventilation wean-
ing in France.
Study design
We conducted a before and after protocol implementa-
tion study with series of measurement over time inter-
rupted by an intervention. Such design is an alternative 
approach used to evaluate the effects of any intervention, 
when randomised controlled trials are infeasible or iden-
tification of a control group impractical [23, 24]. Data 
collection took place during a 12-month pre-implemen-
tation period between January 2013 and December 2013 
and during an 11-month post-implementation period 
between May 2014 and March 2015. The post-implemen-
tation data collection period started 4  months after the 
implementation of the protocol in January 2014. Dur-
ing this 4-month lag, the protocol was introduced and 
explained to all the nurses and medical staff and no data 
was collected.
Drugs
During all the study period, the standard therapy was 
the association of an opioid (sufentanil initiated at 
0.2–0.3  µg/kg/h) and a hypnotic (midazolam initiated 
at 0.05–0.1 mg/kg/h and/or ketamine initiated at 1 mg/
kg/h), both in continuous intravenous perfusions, with 
allowed boluses. During continuous sedation wean-
ing, other treatments could be administered such as 
methadone, hydroxyzine, clonidine, and long half-life 
benzodiazepines or neuroleptics according to the PICU 
guidelines.
Instrument
COMFORT scale and COMFORT behaviour scale are 
the only validated sedation scales for mechanically venti-
lated children. COMFORT-B scale includes 6 behavioural 
items which are state of awakening, levels of agitation, 
spontaneous ventilation, characteristics of movements, 
muscular tone, and faces. Contrary to original COM-
FORT scale, it does not contain physiological items.
Target ranges are inspired from the study of Ista et al. 
[7] that suggests that a COMFORT-B score between 
6 and 10 is associated with excessive sedation, a score 
between 18 and 30 with insufficient sedation, and a score 
between 11 and 17 with adequate sedation.
To evaluate withdrawal symptoms, Franck et  al. [25] 
described the Withdrawal Assessment Tool-1 (WAT-1) 
and proved that it had a good specificity and sensibil-
ity to predict withdrawal symptoms. It was later widely 
validated by the RESTORE Investigative Team [26]. The 
WAT-1 score contains clinical observations before and 
after stimulation, the score ranges from 0 to 12, and a 
score ≥3 indicates withdrawal symptoms.
Intervention plan
The implementation of the nurse-driven sedation proto-
col in the PICU started in January 2014 and was devel-
oped by two paediatric intensivists inspired by the 
experience of other PICU and local practices. During 
4  months, training courses were organised by the two 
paediatric intensivists to teach and disseminate the pro-
tocol. Four sessions of 1  h were proposed, one for the 
10 physicians and three for the 65 nurses divided into 
groups of about 20 people. During each session, gen-
eral recalls were made about sedation, analgesia, evalu-
ation with COMFORT-B scale; the protocol algorithm 
was detailed and explained; some clinical scenarios 
were discussed to illustrate the protocol use, and then, a 
questionnaire was left at the end of the session. A nurse 
working-group interested in management of pain was 
particularly involved and contributed to diffuse the pro-
tocol to all intensivists and nurses by training courses. 
When questions came up in daily routine, trained nurses 
and physicians were able to answer them and explain the 
algorithm. The sedation scoring system was the COM-
FORT-B scale. The algorithm is shown in Fig.  1; it was 
available at each PICU bed. Initial doses were chosen by 
the physicians, and then, all changes were made by the 
nurses with the aim of attaining an optimal range of anal-
gesia and sedation, which was defined as values from 11 
to 17 on the COMFORT-B score. The first evaluation 
with COMFORT-B was made 1  h after the therapeu-
tics were introduced. If the score was greater than 17, a 
sign of insufficient sedation, the sufentanil dose was first 
raised; after 1 h, if the score was still greater than 17, a 
hypnotic, midazolam, or ketamine dose, depending on 
the physician’s choice, had to be raised. This was done 
alternately every hour until the score reached the optimal 
range. Once the COMFORT-B score was optimal, nurses 
assessed the score every four hours. If maximum doses of 
drugs were reached (midazolam 0.3  mg/kg/h, ketamine 
3 mg/kg/h, or sufentanil 0.4 µg/kg/h), the treating physi-
cian had to be informed. On the other hand, if the score 
indicated oversedation (COMFORT-B less than 11), 
hypnotics and opioids were decreased alternately every 
hour. In addition to the continuous perfusion, boluses 
were allowed every hour, particularly during the nursing 
care. Bolus dose corresponded to the drug’s dose admin-
istered per hour: for example, if sufentanil infusion rate 
is 0.1 µg/kg/h, a bolus of 0.1 µg/kg could be given every 
hour. Before implementing this new strategy, all changes 
in the sedation and analgesia were evaluated by the phy-
sicians, which lengthened the period between the recog-
nition of inadequate sedation and the adaptation of the 
therapeutics.
Patients who needed deeper sedation for medical rea-
sons (for example, those with acute lung or brain injury) 
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had a lower target score on the COMFORT-B (<11). 
Sedation and analgesia were then modified by the phy-
sicians, and the protocol was not applied. Also these 
patients were still included in the study, as all patients 
receiving more than 24 h of sedation.
Measures
The primary outcome measure was duration of 
mechanical ventilation (days), and secondary outcome 
parameters were cumulative doses of drugs including 
continuous perfusion and boluses (unit/kg), duration 
of drug perfusion (h), duration of PICU stay (days), 
occurrence of withdrawal symptoms (evaluated by 
WAT-1 score), and incidence of ventilator-associated 
pneumonia (defined by the CDC criteria [27] and 
expressed in patients by 1000 days of mechanical ven-
tilation). We were also interested by the impact of the 
protocol on evaluation of sedation and analgesia by 
comparing number of assessments by COMFORT-B 
scores per day of ventilation and number of adequate 
(COMFORT-B scores in the optimal range) and inad-
equate scores.
Clinical, epidemiologic, and demographic data were 
also collected including age, weight, medical histories, 
reason for admission, unplanned endotracheal extuba-
tion, severity score (PELOD), and death.
Target: COMFORT-B 11–17
COMFORT-B > 17 COMFORT-B 11–17 COMFORT-B < 11
Give bolus and increase
sufentanil of 0.1 µg/kg/h.
Check the score 1 h later
No change
Check the score every 4 h
Bolus allowed 
(maximum 3 per h)
Decrease midazolam of 
0.05 mg/kg/h
or ketamine by 1 mg/kg/h 
(medical choice)
Check the score 1 h later
COMFORT-B > 17 COMFORT-B < 11
Give bolus and increase
midazolam of 0.05 mg/kg/h or
ketamine of 1 mg/kg/h 
(medical choice)
Check the score 1 h later
Decrease sufentanil by 
0.1 µg/kg/h
Check the score 1 h later
COMFORT-B > 17 COMFORT-B < 11
Give bolus and increase
sufentanil of 0.1 µg/kg/h.
Check the score 1 h later
Decrease midazolam of 
0.05 mg/kg/h
or ketamine by 1 mg/kg/h 
(medical choice)
Check the score 1 h later
Intensivists must be informed 
if:
- midazolam > 0.3 mg/kg/h
- sufentanil > 0.4 µg/kg/h
- ketamine > 3 mg/kg/h
If drugs are stopped, 
intensivists must be informed
Fig. 1 Nurse-driven sedation protocol
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Data collection
All data were extracted from patients’ computerised 
medical charts (ICCA®, Philips IntelliSpace Critical Care 
and Anesthesia).
Statistical analysis
With about 100 children per period, a pre- versus post-
implementation test of means would have 80% power to 
detect a mean reduction in the mechanical ventilation of 
2 days assuming a standard deviation of 5 and alpha = 5%.
Means and standard deviations were reported for con-
tinuous variables, and percentages and frequencies for cat-
egorical variables. First, outcomes were compared between 
pre- and post-implementation periods using Wilcoxon’s 
test for continuous variables and Chi-square test for cat-
egorical variables. Comparison in duration of mechanical 
ventilation was controlled for age and reason of admission.
In a second step, to control for secular trends, we used 
segmented regression analyses of interrupted time series to 
assess the effect of the implementation of the nurse-driven 
sedation protocol on outcomes [28, 29]. We estimated the 
time trend in outcomes before the implementation, the 
change in trend after the implementation, and the change in 
level at the initiation of the nurse-driven sedation protocol 
on outcomes. The pre- and post-implementation period was 
divided into 4 periods of 3 months. Outcomes were aggre-
gated into mean in 3-month intervals, the trimester repre-
senting the unit of analysis. An indicator variable was used 
to define the implementation of the nurse-driven sedation 
protocol, with a value of 0 given to the trimesters before 
implementation and a value of 1 given to the trimesters after 
implementation (beginning in May 2014). Model param-
eters included intercept, time trend before implementation, 
level change immediately after implementation, and change 
in time trend after implementation. The model is presented 
in “Appendix”. A p value <0.05 was regarded as statistically 
significant. The segmented regression analysis was not per-
formed for withdrawal symptoms and ventilator-associated 
pneumonia because of the few events occurred over the 
study period. Statistical analyses were performed with SAS 
software (SAS Institute, Cary, NC, version 9.3).
Results
Patients’ characteristics
A total of 104 patients were enrolled during the 
12-month pre-implementation period and 93 patients 
during the 11-month post-implementation period. 
Patients’ characteristics are presented in Table 1. There 
Table 1 Patient characteristics over the study period
* Reason for admission: p = 0.039 is the p value of the difference between surgical and non-surgical admission diagnosis; p = 0.131 is the p value of the difference 






Male, N (%) 61 (59) 57 (61) 0.706
Age at admission (years), mean (SD) 4.9 (5.4) 5.2 (5.3) 0.607
Median [Q1–Q3] 2.2 [0.4–9.6] 3.2 [0.4–9.7]
Weight at admission (kg), mean (SD) 20.3 (18.9) 20.7 (17.8) 0.660
Reason for admission, N (%)*
 Surgical cause 25 (24) 35 (38) 0.039
 Non-surgical cause 79 (76) 58 (62) 0.131
  Neurology 41 (39) 28 (27)
  Respiratory 29 (29) 22 (21)
  Sepsis 9 (9) 8 (8)
Medical history, N (%) 18 (17) 15 (16) 0.825
 Prematurity <34 weeks 8 (8) 4 (4) 0.267
 Chronic respiratory failure 1 (1) 3 (3) 0.345
 Congenital cardiopathy 5 (5) 6 (6) 0.616
 Chronic cardiac failure 0 (0) 2 (2) 0.212
 Encephalopathy 8 (8) 5 (5) 0.513
PELOD score, mean (SD) 18.8 (11.6) 17.5 (11.6) 0.746
Death, N (%) 18 (17) 13 (14) 0.522
Inotropic drugs, N (%) 75 (72) 67 (72) 0.991
Neuromuscular blockade, N (%) 38 (37) 33 (35) 0.878
Dialysis, N (%) 2 (2) 4 (4) 0.424
Unplanned extubation, N (%) 4 (4) 3 (3) 1.000
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were no significant differences between study periods 
except for the type of admission (p = 0.039). In the pre-
implementation period, 24% of patients were admitted 
for surgical cause and 38% during the post-implementa-
tion period.
Primary outcome
As there were significantly more surgical patients in 
the post-implementation period (p  =  0.039; Table  1), 
we compared the duration of mechanical ventilation 
and PICU length of stay according to the admission 
diagnosis. We found a significant shorter duration of 
mechanical ventilation in patient admitted for surgi-
cal reasons: 5.8  ±  5.3 vs 8.2  ±  6.9  days for non-sur-
gical pathologies (p =  0.016). In the year prior to the 
implementation of the nurse-driven sedation proto-
col, the mean duration of mechanical ventilation was 
8.3  ±  7.3  days and decreased to 6.6  ±  5.6  days after 
the implementation. The difference between the two 
periods was not significant (p = 0.094) (Table 2), even 
after controlling for age at admission and reason for 
admission (p = 0.129, Additional file 1).
Secondary outcomes
No significant change was shown in the PICU length of 
stay or in the medication uses (Table 2).
The rate of withdrawal symptoms was 23% (24/104) in 
pre-implementation and decreased non-significantly to 
14% (13/104) in post-implementation period (p = 0.103) 
without increasing additional drugs (Additional file  2). 
The intervention had no significant effect on the rate of 
ventilator-associated pneumonia (reduction from 14 to 
10%, p = 0.309) and on the incidence of ventilator-asso-
ciated pneumonia (reduction from 17.4 to 14.7 per 1000 
ventilator days, p = 0.690).
Evaluation of sedation and analgesia: scoring with the 
COMFORT-B scale (secondary outcomes)
The mean number of time COMFORT-B was per-
formed in the pre- and post-implementation groups 
was 3.9 ± 2.5 and 6.6 ± 3.5 (times per day of mechani-
cal ventilation), respectively. The difference between the 
two periods was significant (p < 10−3). As shown in Fig. 2, 
segmented regression analysis confirmed the significant 
immediate increase of +2.8 times (SD = 0.4) in the num-
ber of assessment with the COMFORT-B scale per day 
on mechanical ventilation after protocol implementation 
(p = 0.0004).
The median COMFORT-B score per patient was 8 
(range 6–19) during the pre-implementation period 
and 9.5 (range 6–15.5) during the post-implemen-
tation period. The difference between the two peri-
ods was significant (p  =  0.002). Figure  3 shows the 
distribution of COMFORT-B scoring per patient for 
each period. The mean number of adequate (scores 
between 11 and 17) levels of sedation and analgesia 
was significantly greater after protocol implementa-
tion (22.2 vs 31.7%, p < 10−3), whereas the mean num-
ber of excessive (scores  <  11) levels of sedation and 
analgesia decreased significantly from 73.3% in the 
pre-implementation to 60.7% in the post-implementa-
tion period (p < 10−3).
Segmented regression analysis (additional analyses 
for primary and secondary outcomes)
The results from segmented regression analysis are 
presented in Table  3 and Fig.  4. Before the imple-
mentation of the nurse-driven sedation protocol, the 
duration of the mechanical ventilation decreased 
each semester by 0.35 ±  0.42  days. The intervention 
had no significant immediate effect on the duration 
Table 2 Duration of mechanical ventilation, PICU length of stay, and medication uses over the study period






Duration of mechanical ventilation (days) 5.6 (3.2–10.5) 4.8 (2.8–8.3) 0.094
PICU length of stay (days) 9.0 (5.0–15.2) 9.8 (4.9–14.5) 0.767
Sufentanil
 Daily dose (μg/kg/day) 5.6 (3.8–8.7) 6.3 (4.7–8.7) 0.185
 Duration of administration (h) 99 (54–170) 78 (47–133) 0.097
Midazolam
 Daily dose (mg/kg/day) 3.2 (2.1–4.9) 2.9 (2.2–4.4) 0.223
 Duration of administration (h) 112 (60–171) 89 (44–155) 0.149
Ketamine
 Daily dose (mg/kg/day) 46.1 (29.6–57.1) 41.9 (24.3–51.3) 0.067
 Duration of administration (h) 110 (54–167) 94 (46–155) 0.574
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Fig. 2 Mean number of COMFORT-B assessment per day on mechanical ventilation over time. Observed data are presented with black dots, and 
predicted data with segmented regression analysis are presented in blue for pre-implementation and red for post-implementation. Vertical dashed 
lines represent the 4-month implementation period
Fig. 3 Distribution of COMFORT-B scores per level of sedation and analgesia before and after the protocol implementation. Bars represent 95% 
confidence interval, ***p < 0.001
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Table 3 Analysis of changes in the level and trend in outcomes after implementation of the nurse-driven sedation protocol
Negative numbers represent a decline, and inversely, positive numbers represent an increase in outcomes values
a Mean change (standard deviation in brackets) of each outcome per semester before the implementation of the protocol
b Expressed as a mean change (standard deviation in brackets) of each outcome immediately after implementation of the nurse-driven protocol compared with the 
pre-implementation period
c Mean change (standard deviation in brackets) of each outcome per semester after the implementation of the protocol compared with the pre-implementation 
period
Outcomes Pre-implementation period




From 1 May 2014 to 31 March 2015
(n = 93 children)
Overall trend before the 
implementation of pro-
tocola
p value Immediate change 
after the implementation 
of protocolb




Duration of mechanical 
ventilation (days)
−0.35 (0.42) 0.450 0.17 (1.64) 0.923 −0.05 (0.60) 0.933
PICU length of stay (days) −0.71 (0.90) 0.476 6.56 (3.49) 0.134 −1.07 (1.28) 0.450
Sufentanil
 Daily dose (μg/kg/day) 0.19 (0.31) 0.574 0.38 (1.22) 0.770 −0.21 (0.44) 0.668
 Duration of administra-
tion (h)
−3.31 (4.79) 0.528 −1.42 (18.6) 0.943 −1.32 (6.78) 0.855
Midazolam
 Daily dose (mg/kg/day) −0.12 (0.18) 0.541 0.04 (0.69) 0.955 0.02 (0.25) 0.944
 Duration of administra-
tion (h)
0.27 (3.59) 0.944 −13.4 (13.9) 0.389 −3.39 (5.07) 0.541
Ketamine
 Daily dose (mg/kg/day) 1.11 (2.96) 0.727 1.97 (11.5) 0.872 −3.06 (4.19) 0.506
 Duration of administra-
tion (h)
7.06 (21.2) 0.756 −4.82 (82.1) 0.956 −17.2 (30.0) 0.598
Fig. 4 Duration of mechanical ventilation over time. Observed data are black dots, and predicted data with segmented regression analysis are blue 
for pre-implementation and red for post-implementation. Vertical dashed lines represent the 4-month implementation period
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of the mechanical ventilation (p  =  0.923 for imme-
diate change after the implementation) and led to a 
non-significant change in trend over semesters fol-
lowing the implementation (p  =  0.933 for change in 
trend after the implementation). Finally, the duration 
of the mechanical ventilation decreased significantly 
by 0.35  ±  0.10  days per semester over all the study 
period (p = 0.012, Fig. 4).
Regarding secondary outcomes, we found no signifi-
cant immediate level change or slope change after the 
implementation of the nurse-driven sedation protocol. 
Moreover, the PICU length of stay and the daily dose of 
sufentanil and ketamine were stable over time, whereas 
the daily dose of midazolam, and the duration of admin-
istration of sufentanil and midazolam decreased signifi-
cantly over the study period (−0.10  ±  0.04  µg/kg/day 
per semester for the daily dose of midazolam, p = 0.051; 
4.2 ± 1.1 h per semester for the duration of administra-
tion of sufentanil, p = 0.010; and −3.7 ± 1.0 h per semes-
ter for the duration of administration of midazolam, 
p = 0.010).
Discussion
Guided sedation has been widely developed in recent 
years. However, to the best of our knowledge, there are 
no large-cohort studies describing a positive effect on the 
duration of mechanical ventilation in a paediatric popu-
lation. Thus, we developed a sedation protocol and evalu-
ated its influence on practices.
Population
The median age of the population in each period was 2 
and 3 years, respectively, which is similar to that of other 
studies [15, 18]. The mortality rate in our study popula-
tion (17%) was higher than in our overall PICU popu-
lation (5%). However, this higher mortality rate could 
be expected as ventilated patients are likely to be more 
severely ill, as illustrated by the high mean PELOD scores 
in both groups: 18.8 and 17.5.
Population targeted by the protocol
We limited the nurses’ actions to the group “adequate 
sedation” with scores between 11 and 17. In case of deep 
sedation required for medical reasons, expected scores 
ranged from 7 to 11. In this setting, any modification of 
sedation or analgesia had to be validated by the physi-
cian. Recently, Gaillard-Le Roux et  al. [30] showed in a 
paediatric study that a nurse-driven protocol was also 
applicable for deeply sedated patients, with lower target 
scores. Generalising the use of the protocol to all patient 
categories is certainly a good manner to enhance its 
acceptability and its efficacy.
Impact on duration of mechanical ventilation
All recent large-cohort studies chose duration of 
mechanical ventilation as the primary outcome, but none 
were able to show a significant reduction in mechanical 
ventilation [15–18]. Except for the study by Curley et al., 
which was a randomised, controlled trial in children with 
ARDS, the other studies were designed as prospective or 
retrospective before and after studies.
Either with nurse-driven sedation protocol or with 
daily interrupted sedation, obtaining significant reduc-
tion in mechanical ventilation appeared to be difficult 
in PICU. This may be linked to various factors which 
may contribute to delay mechanical ventilation weaning, 
especially in younger children: difficulties to evaluate 
pain and comfort, fear of extubation failure, hemody-
namic complications with sedation drugs, and occur-
rence of withdrawal symptoms. A wide weight range 
of children is admitted in PICUs (i.e. infants weighting 
less than 10 kg as well as children and teenagers weigh-
ing sometimes more than 80  kg), and there are prob-
ably important differences, especially pharmacologic 
ones, according to the age and to the reason for admis-
sion. A recent French paediatric study showed in a sub-
group analysis a shorter length of mechanical ventilation 
among children older than 12  months after implemen-
tation of the protocol [30]. The only large RCT pub-
lished on this subject [18] included patients with ARDS 
only, who present specific characteristics: long respira-
tory recovery, use of deep sedation and neuromuscular 
blockades; in consequence, their results could not be 
generalised to the overall PICU population. However, 
we did not performed subgroups analysis as the power 
of our study did not allow to. Future larger studies could 
bring interesting results on the use of guided sedation 
and analgesia in general population in PICUs and in spe-
cific groups of patients according to age or admission 
diagnosis.
Impact on drug prescriptions
After implementation of a nurse-driven sedation proto-
col, Keogh et al. [17] showed a reduction in the duration 
of morphine administration of 19  h, and Neunhoeffer 
et  al. [15] described a significant reduction in benzodi-
azepine cumulative doses after application of the proto-
col. Deeter et  al. [16] compared patients treated under 
a nurse-driven protocol to a historic cohort and high-
lighted that the protocol enabled the duration of sedative 
drugs to be reduced from 7 to 5  days. For our part, we 
showed a downward trend in the duration of sufentanil 
administration and daily doses of ketamine in the post-
implementation period, results not confirmed by seg-
mented regression analysis.
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Impact on withdrawal symptoms
In children, withdrawal symptoms occurred frequently 
when the analgesics and sedatives are stopped. The inci-
dence of withdrawal reported in the literature varies from 
10% [31], 37% [4], and even 48% [32]. Withdrawal symp-
toms are linked to discontinuation of either opioids or 
benzodiazepines and result from central nervous system 
irritability, gastrointestinal dysfunction, and autonomic 
nervous system dysfunction. The WAT-1 score is now used 
routinely in our PICU to detect occurrences of withdrawal 
[25, 26]. In their before and after study design including 
165 and 172 patients, respectively, Neunhoeffer et al. [15] 
showed that the use of a sedation protocol enabled signifi-
cant reductions in the incidence of withdrawal symptoms 
from 23.6% before and 12.8% after implementing the pro-
tocol (p = 0.005). In our population, withdrawal symptoms 
tended to decrease without reaching significance.
Impact on evaluation of sedation and analgesia
One of our main positive results was the improvement 
in sedation and analgesia evaluation. A fear could be that 
guided sedation led to insufficient sedation. In their ran-
domised clinical trial, Curley et  al. [18] described more 
reports of agitation and elevated pain scores in the group 
under guided sedation. In our experience, we recorded 
no increase in the number of COMFORT-B scores >17 or 
in unplanned endotracheal extubations.
Limitations of the study
Our study has several limitations. First of all, it was not 
a randomised controlled trial but a “before and after” 
observational study performed within a single PICU, as 
majority of precedent studies [15, 17]; thus, results could 
possibly be influenced by temporal trend rather than to 
the protocol efficiency itself. This phenomenon was well 
described when interventions diffuse into widespread 
practice in an uncontrolled way while studies evaluat-
ing them are under way; for example, implementation 
of guidelines could have a positive impact before their 
official publication [33, 34]. Nevertheless, there was no 
change in general treatment or ventilator care strategies 
during the two study periods. Even so, we cannot exclude 
that implementation of the protocol could have made 
physicians and nurses more careful and aware of the 
importance of reducing unnecessary sedation and ven-
tilation. However to limit this bias, we performed a seg-
mented regression analysis.
Oversedation persisted in the post-implementation 
period, and this is probably one of the major limitations 
of our work. The proportion of scores <11 per patient 
found in our study is more important than reported in 
literature [5]. This result could be explained by the fact 
that any patient receiving more than 24 h of sedation was 
included in our study, even patients for whom the pro-
tocol was not applied, like patients under deep sedation 
for medical reasons and patients under neuromuscu-
lar blockade. Compared to other studies, patients under 
neuromuscular blockade were not excluded from our 
study; the use of this treatment was often limited in time, 
mainly in patients with respiratory disease (i.e. ARDS), 
and the protocol was successfully applied after the neu-
romuscular blockade discontinuation. Even if the pro-
portion of patients receiving neuromuscular blockades 
is comparable between the two groups, the assessments 
under these medications may partly explain the high pro-
portion of oversedation observations.
Another point to explain oversedation was probably the 
imperfect compliance to the protocol and the reluctance 
of nurses to decrease the drugs especially in a calm and 
comfortable patient. Thus, lack of compliance could have 
a major negative impact on our results. Unfortunately, in 
this study, the protocol compliance was not assessed; it 
should be the aim of a further study; for example, it could 
be interesting to analyse the discordances between the 
COMFORT-B scores and the nurses’ actions.
Implementing the protocol corresponded with major 
changes in practice and considerable modification of the 
medical staffs’ and nurses’ roles, giving more respon-
sibility and independence to the PICU nurses. In previ-
ous studies, nurses seemed the best able to evaluate the 
patient’s sedation state and to adapt the therapeutics [17]. 
We certainly could have enhanced the quality of our work 
with realising a quality evaluation of our protocol. Keogh 
et  al. [17] carried out a staff survey after their protocol 
implementation; they demonstrated that negative points 
were 1—difficult comprehension of the protocol, 2—need 
for full concentration with attention to details, 3—prac-
tice to become familiar with, and 4—lack of medical lead-
ership. In our study, we should wonder if the 4-month 
period of adaptation was long enough, if all the nurses 
had received clear information and if sufficient continu-
ous training was done after the implementation period.
Recently, Deeter’s team re-evaluated the effect of a 
nurse-driven protocol 5  years after its implementation 
[35]. Whereas in 2008, just after the protocol implementa-
tion, they showed a reduction in the median total sedation 
days from 7 to 5 days, in 2013, 5 years later, they obtained 
longer duration of total sedation days, mechanical ventila-
tion, and PICU length of stay. The authors involved lack of 
routine feedback and of ongoing education programme, 
loss of interest, and redirection of priorities to other 
clinical concerns. With our guided sedation protocol, we 
replaced sedation and analgesia at the centre of our care; 
in the future, it will require good communication and in-
service training in order to ensure long-term adherence to 
the protocol and to sustain efforts over time.
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Lastly, we unfortunately did not assess the impact of 
our nurse-driven sedation protocol on outcomes such 
as delirium and post-traumatic stress disorder (PTSD) 
which are important issues for patients admitted to 
intensive care units. Indeed, the reported prevalence of 
paediatric delirium in PICU varies between 4 and 29% 
[36] and may be attenuated by better sedation and anal-
gesia management. Regarding PTSD, a recent review [37] 
reported an incidence in adults of 17–34% one year after 
intensive care unit discharge. Risk factors seemed to be 
anterior psychological disorders, benzodiazepine admin-
istration, and delirious memories facilitated by pain or 
agitation. In children, Colville et al. [38] questioned 102 
children (7–17  years of age) three months after their 
hospital discharge, according to the “Children’s Impact 
of Event Scale” and found an incidence of PTSD of 28. 
Administration of opioids or benzodiazepines for more 
than 48  h was significantly associated with the exist-
ence of delirious memories. The risk of occurrence of 
PTSD was 3 times greater when delirious memories were 
related. In the future, it could also be relevant to evaluate 
whether or not guided sedation protocols could influence 
delirium prevalence and long-term psychological compli-
cations in children.
Conclusion
We conclude that implementation of a nurse-driven seda-
tion protocol was feasible and was accepted as standard 
practice in a PICU. Evaluation of sedation and analgesia 
with the COMFORT-B score was improved by the proto-
col. The total number of scores and, above all, the num-
ber of optimal scores were significantly increased after 
the protocol implementation. The duration of mechani-
cal ventilation, duration of sufentanil administration, and 
daily dose of ketamine tended to decrease thanks to the 
use of the protocol. Withdrawal symptoms seemed to be 
less frequent in the post-implementation period. Because 
of the design of the study, we cannot confirm that the 
results are linked to the protocol implementation and not 
to temporal trends in practice.
Abbreviation
PICU: paediatric intensive care unit; COMFORT-B score: COMFORT behaviour 
score; ARDS: acute respiratory distress syndrome; PELOD: paediatric logistic 
organ dysfunction; WAT-1: withdrawal assessment tool 1; PTSD: post-traumatic 
stress disease.
Additional files
Additional file 1. Duration of mechanical ventilation and PICU lenght of 
stay in pre- and post- implementation period after adjustment on reason 
for admission.
Additional file 2. Pre-post analysis of additional drugs (for withdrawal 
symptoms).
Authors’ contributions
LD and FB designed the study and the data collection methods, participated 
in data collection and analysis, and prepared the manuscript. AD and ST were 
responsible for the statistical analyses and were involved in the manuscript 
preparation and revisions. They helped to procure the project funding. 
EJ supervised the entire study, was involved in its design, conduct, result 
interpretation and critically reviewed the manuscript. All authors read and 
approved the final manuscript.
Author details
1 Service de réanimation pédiatrique, Hospices Civils de Lyon - Hôpital Femme 
Mère Enfant, 59, Boulevard Pinel, 69500 Bron, France. 2 Université Claude-
Bernard Lyon 1, 69008 Lyon, France. 3 Pôle information médicale évaluation 
recherche, Hospices Civils de Lyon, 162 avenue Lacassagne Bâtiment A, 
69003 Lyon, France. 4 HESPER EA 7425, Université Claude Bernard Lyon 1, 
69008 Lyon, France. 
Acknowledgements
The authors are grateful to Amélie Zelmar (Hospices Civils de Lyon, Pôle 
information médicale évaluation recherche) and Céline Giroud (Hospices Civils 
de Lyon, Centre d’Investigation Clinique) for her contribution in data manage-
ment and statistical analysis. LD is grateful to Frederic Valla, M.D, (Service de 
réanimation pédiatrique, Hôpital Femme Mère Enfant) for his contribution 
to the insertion of the protocol in the computerised medical charts (ICCA®, 
Philips IntelliSpace Critical Care and Anesthesia) and for his assistance in 
English writing.
Competing interests
The authors declare that they have no competing interests.
Availability of data and materials
Ethical restrictions prevent public sharing of data. Editors, reviewers, and 
interested researchers should contact the corresponding author to request 
data access.
Ethics approval and consent to participate
The study was approved by the ethical committee, CPP Sud-Est II, in August 
2014. In the PICU, all parents were informed that observational studies were 
performed in the unit and were aware that clinical data extracted from the 
computerised medical charts of their children could be used for scientific 
research.
Funding
This investigation received financial support from APICIL foundation and ALLP 
association.
Appendix: Interrupted time series analysis
We estimated the model:
where:
  • Yt indicates the mean outcome at trimester t.
  • β0 estimates the baseline level of the outcome at the 
beginning of the study period (1st trimester of the 
overall study period).
  • “Time” is an indicator of time and covers the 9 tri-
mesters of study (variable coded 1–9). The coefficient 
β1 on this variable captures the overall secular trend 
in means outcomes over the study period.
  • “Intervention” is a binary variable indicating the time 
periods in which the nurse-driven sedation protocol 
was in effect. Intervention is coded 0 for trimesters 
Yt = β0 + β1 ∗ Timet + β2 ∗ Intervention
+ β3 ∗ TimeAfterIntervention+ et
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before the implementation (before January, 2014) 
and 1 for trimesters after the implementation of the 
nurse-driven sedation protocol (after January, 2014). 
The coefficient β2 on this variable is interpreted as 
the immediate change in the level of the outcomes.
  • “TimeAfterIntervention” is coded 0 for trimesters 
before the implementation (before January, 2014) and 
sequentially numbers time periods after implementa-
tion (1–4). The coefficient β3 on this variable captures 
the continuing effect of the nurse-driven sedation 
protocol that is the slope of the change in successive 
time periods.
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